“Our collective goal is not only to respond, but to strengthen resilience for the future.” –Vanina Laurent-Ledru, Chief Public Health & Government Affairs Officer for bioMérieux. Read more about our ongoing response to the #Ebola outbreak: spkl.io/633217M0uf #MedSky #IDsky

Syndromic Trends reporting shows a decrease in the test positivity rate for parasites—a sign that the #Cyclospora outbreak may finally be slowing. John Osiecki, Vice President of Medical Affairs for bioMérieux, recently spoke with The Guardian on this topic: spkl.io/633207zFXY

Diagnostic preparedness doesn’t just mean having tests on hand for well-established infectious disease threats—it means working to stay ahead of potential outbreaks. Find out more on our website: spkl.io/633227zjek

The #Ebola outbreak is now the fastest growing on record, according to the WHO. Long-term investment in public health is necessary to prevent and minimize the impact of future outbreaks. Read more about our efforts to help fight Ebola: spkl.io/633287Kkaa

Cyclosporiasis cases continue to rise across the United States. We're now seeing 18% of tests are returning a positive result for parasites on syndromictrends.com.

Listen as Marc Haribou, Vice President – Africa for bioMérieux, shares his perspective on diagnostics, monitoring, and surveillance for infectious disease outbreaks. Read more about our response to the #Ebola outbreak: spkl.io/633297JUlU

At least 34 states are now reporting cases of cyclosporiasis. With WATCHFIRE™, public health authorities can test wastewater for more than 20 pathogens, including cyclospora. Learn more: spkl.io/633207ya14

The current Cyclospora outbreak highlights how difficult it is to diagnose and treat illnesses with similar symptoms. Learn how testing, community monitoring, and reporting can help: spkl.io/633247yiAK

Anonymized data from BIOFIRE® FIREWORKS™ is tracking the ongoing outbreak of Cyclospora across the U.S. We’re working with the CDC and health systems to use this data to support community preparedness, outbreak awareness, and informed resource planning. syndromictrends.com

💡ICM recommendations. New #diagnostic criteria. Molecular diagnostics. 🎙️ Join Prof. Indelli & Dr. Esteban on July 20 for a webinar on the recent changes in prosthetic joint infection diagnosis. Register now: spkl.io/633217HHtd #IDsky

Vanina Laurent-Ledru, Chief Public Health & Government Affairs Officer for bioMérieux, explains the company’s role in responding to an infectious disease outbreak. Learn more about our public health mission and response to the current #Ebola outbreak: spkl.io/633237GibH #IDSky

Join us and @biomerieux.com on Thurs. July 16 for a lunch symposium on gender affirming care and vaginal microbiomes in transgender men. Drs. Van Gerwen & Sobel will discuss barriers to sexual healthcare as well as vaginitis & its possible causes. Learn more: www.idsog.org/2026-annual-...

New study in @cidjournal.bsky.social (11k+ pts, 36 VA hospitals) shows multiplex #pneumonia testing associated with earlier antimicrobial de‑escalation and improved early appropriate therapy, particularly with strong ASP. Real‑world DiD design. #MedSky #IDSky

Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study

We conducted a national, multicenter retrospective study of ICU patients with pneumonia admitted to Veterans Health Administration hospitals.

spkl.io

#Diagnostics are crucial for managing the response to the #Ebola outbreak. Hear from Dr. Chuck Cooper, Chief Medical Officer for bioMérieux, as he explains why. Learn more from our experts & how we are supporting health ministries in the region: spkl.io/6332871I4r #IDSky #MedSky

Diagnostics are a first line of defense in #Ebola response. We’re accelerating BIOFIRE® shipments and working with partners to expand testing capacity, supporting earlier detection and stronger #outbreak control. Explore expert insights: spkl.io/633247EyL6 #IDSky #Africa

Mobilizing Ebola Diagnostics to Africa

Learn how bioMérieux is supporting Ebola outbreak response efforts through rapid diagnostic solutions, expanded testing capacity, and public health partnerships.

spkl.io

How is Fast AST impacting patient outcomes? A look at how VITEK® REVEAL™ is being used in practice and helping guide clinical decisions. 🔔 Don't miss our #webinar tomorrow, June 17: spkl.io/633297DcV1 #Diagnostics #Sepsis #Antibiograms #Antibiotics

Fast AST Webinar - June 17, 2026

Register now!

spkl.io

#Kidney Transplants: Torque Teno Virus #biomarker can safely guide a more personalized immunosuppression. The use of bioMérieux’s TTV R-GENE® assay during the TTVGuideTX interventional trial shows how diagnostics can help optimize care for patients at risk. @ttvguidetx.bsky.social #MedSky

http://spkl.io/6332878e9y

Biomarker-guided immunosuppression following kidney transplantation successfully tested

spkl.io

Fast AST is changing how laboratories operate. What does that look like in practice? 🔔 Join us for an engaging session with Dr. Everson as he explores the real-world use of VITEK® REVEAL™, from implementation considerations to clinical outcomes. #MedSky #Diagnostics #Webinar

FAST AST in Practice: Insights from a USA tertiary care hospital

Wed, Jun 17, 2026 4:00 PM - 5:00 PM CEST

spkl.io

How is AMR shaping cancer care? Join Webinar 1 of the AMR & Cancer series: 🔍 Defining the Problem 📅 8 June 2026 ⏰ 11:30–12:30 BST Featuring Prof Anna Olsson-Brown & Dr Helena Carreira. Register: https://microb.io/4dcyolJ #KOAMR #AMR #Oncology

Outpatient antimicrobial stewardship needs practical solutions. Join #AMR Pathways on June 3 at 1 PM ET with Rebekah H. Wrenn, PharmD, BCIDP, to explore how diagnostics & collaboration enhance community care. ➡️ bit.ly/4dvzyZX P.A.C.E.® credit available. #AntimicrobialResistance #MedSky

In a first-of-its-kind study to evaluate the impact of rapid ID/AST diagnostics, faster test results were found to reduce the number of sepsis cases and avoidable deaths, as well as lower the amount of post-sepsis complications. #IDSky 🧪 Office of Health Economics bioMérieux 🔗 bit.ly/4efMrJA

The Global-PPS community gathered on 17 April for its annual meeting at #ESCMIDGlobal: over 270 participants engaging in powerful conversations on real-world antimicrobial stewardship. Plus: 4 research posters on antibiotic use from the Philippines to northern Syria. -> shorturl.at/PWJ28

Annual Global-PPS Meeting and ESCMID Global 2026 - Global PPS

Last week, the Global Point Prevalence Survey community gathered for its annual meeting, held in collaboration with bioMérieux at the opening of the ESCMID Global 2026 congress in Munich. With 240 par...

shorturl.at

Discover our new Product Education Hub, a non-promotional, open-access space to deepen diagnostic understanding & support informed decisions. It provides evidence-based resources on our #diagnostic solutions, including VITEK®, BACT/ALERT®, and BIOFIRE®. spkl.io/63321AfJ7x #MedEd

A multi-country health economic analysis by the OHE (@ohenews.bsky.social) shows that deploying fast #diagnostics early is expected to reduce progression to #sepsis and generate consistent system-level savings across all G7 countries. Read more: spkl.io/63325A4Y1h

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

spkl.io

📢 Our 2025 Annual Report is now online! Explore the milestones shaping public health and advancing #diagnostics to strengthen the fight against #AMR and #sepsis. 👉 spkl.io/63321ANwxl

bioMérieux Annual Report 2025

Together we help make the world a healthier place

spkl.io

📢 GO-Dx launched from the #OneHealthSummit: a joint compact to expand diagnostic access and align surveillance + stewardship across sectors. 🎯 The goal: faster detection, appropriate treatment, and more resilient systems in the face of growing global health threats. #AMR #OneHealth #Diagnostic

Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats

A coalition of more than 20 international partners announced the Global One Health Diagnostics Access Compact (GO-Dx) during the G7 One Health Summit in Lyon, France. This new initiative serves as a catalyst for international leaders across different sectors to advance progress toward expanding diagnostics access, enabling early detection and better surveillance, and improving response against existing and emerging threats across human, animal, and environmental health. By aligning efforts, this group aims to strengthen global preparedness through science based One Health solutions.

spkl.io

Early, interpretable alerts can give clinicians valuable time to act. A new study shows how predictive AI using routine ICU EHR data can anticipate #sepsis deterioration hours earlier, with potential application across critical care. Read more: spkl.io/63327A28TR #IDsky #MedSky

Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

spkl.io

📢 The final agenda for the #GlobalPPS Annual Meeting is now available! The meeting's theme is: Insights into antimicrobial consumption for enhanced #AntimicrobialStewardship. Check out the agenda and register here: www.global-pps.com/events/ #ESCMIDGlobal #AMR @biomerieux.com

🎧In this month's Microbe Talk, we welcomed guests Dr Alicia Demirjian (UK Health Security Agency) and Dr Yoann Personne (bioMérieux) to explore an underdiscussed corner of the antimicrobial resistance conversation: its management with sepsis. Listen in here🔗 https://microb.io/4bMIN70

bioMérieux is investing in Plair to advance real‑time microbial detection and air sampling with RAPID C+. This collaboration supports stronger pharma environmental monitoring and faster, safer cleanroom decisions. ➡️ Read the article about this new investment: spkl.io/63325A0Ftt